Soley Pharmaceutical Private Limited - Due diligence report
A 360° intelligence report on Soley Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, growt…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Soley Pharmaceutical Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsSoley Pharmaceutical Private Limited is assessed as Low Risk with a Trust Score of 75/100. Soley Pharmaceutical Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Soley Pharmaceutical Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Elevated gearing (D/E 38%).
Charges position: 0 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| REHAN EJAZ KHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SOHAIL MASOOM KHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| FAIZAN KHAN RAZZAQUE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 60 · Distress 75Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 11 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Concept Biomedicals Private Limited | U24232DL2011PTC213744 | Delhi, Delhi, India |
| Biohealthcart Nutrio Private Limited | U93000DL2019PTC350110 | New Delhi, Delhi, India |
| Jef Medisys Private Limited | U74999MH2018PTC303509 | Thane, Maharashtra, India |
| Circulate Pharmaceuticals Private Limited | U74999WB2016PTC218565 | Kolkata, West Bengal, India |
| B.P.S. Pharmaceutical Private Limited | U24100UP2014PTC062465 | Ballia, Uttar Pradesh, India |
| Sterllink Display Private Limited | U74300TN2005PTC055636 | Chennai, Tamil Nadu, India |
| Ariaus Biosciences Private Limited | U36912UP2016PTC075600 | Kanpur, Uttar Pradesh, India |
| Neetaraa Global Exim Private Limited | U24304UP2018PTC106873 | Kanpur, Uttar Pradesh, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Soley Pharmaceutical Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Soley Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Soley Pharmaceutical Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Soley Pharmaceutical Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Soley Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Soley Pharmaceutical Private Limited an active company?
Soley Pharmaceutical Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Soley Pharmaceutical Private Limited financially healthy?
Soley Pharmaceutical Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Soley Pharmaceutical Private Limited?
Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Soley Pharmaceutical Private Limited?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Soley Pharmaceutical Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Soley Pharmaceutical Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Soley Pharmaceutical Private Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.